Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer

Lung Cancer

Volumn 20, Issue 2, 1998, Pages 93-98

  Minotti, V ^a   Crino', L ^a   Meacci, M L ^a   Corgna, E ^a   Darwish, S ^a   Palladino, M A ^a   Betti, M ^a   Tonato, M ^a  

^a POLICLINICO MONTELUCE   (Italy)

Author keywords

Brain metastases; Chemotherapy; Non small cell lung cancer

Indexed keywords

CISPLATIN; TENIPOSIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TENIPOSIDE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0032080147     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00021-X     Document Type: Article

References (23)

1. Nugent J.L., Bunn P.A., Mathews M.J.et al. CNS metastases in small cell bronchogenic carcinoma. Cancer. 44:1979;1885-1893.
2. Hirsch F.R., Paulson O.B., Hansen H.H.et al. Intracranial metastases in small cell carcinoma of the lung and correlation of clinical and autopsy findings. Cancer. 90:1982;2433-2437.
3. Sorensen J.B., Hansen H.H., Hansen M.et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol. 6:1988;1479-1480.
4. Chavantes M.C., Zamorano L., Dujovny M.et al. Management of lung cancer with brain metastases [Abstr 824]. Proc Am Soc Clin Oncol. 7:1988;213.
5. Patchell R.A., Tibbs P.A., Walsh J.W.et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 322:1990;494-500.
6. Noordijk E.M., Vecht C.J., Haazma-Reiche H. The choice of treatment of single brain metastases should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 29:1994;711.
7. Twelves C.J., Souhamii R.L., Harper P.G.et al. The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. Br J Cancer. 61:1990;147-150.
8. Kristjansen P.E.G., Hansen H.H. Brain metastases from small cell lung cancer treated with combination chemotherapy. Eur J Cancer Oncol. 24:1988;545-549.
9. Lee J.S., Benjamin R.S., Murphy W.K.et al. Successful treatment of brain metastases with systemic chemotherapy (Chemo) in small cell lung cancer (SCLC) [Abstr 764]. Proc Am Soc Clin Oncol. 7:1988;198.
10. Rosner D., Nemoto T., Lane W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer. 58:1986;832-839.
11. Cocconi G., Lottici R., Bisagni G.et al. Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest. 8:1990;327-334.
12. Zucchetti M., Rossi C., Knerich R.et al. Concentrations of VP16 and VM26 in human brain tumors. Ann Oncol. 2:1991;63-66.
13. Postmus P.E., Haaxama-Reiche H., Sleyfer D.T.et al. High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results. Eur J Resp Dis. 70(suppl 149):1987;65-71.
14. Giaccone G., Donodio M., Bonardi G.M.et al. Teniposide (VM26): an effective treatment for brain metastases of small cell lung carcinoma of the lung. Eur J Clin Oncol. 24:1988;629-631.
15. Postmus P.E., Smit E.F., Haaxma-Reiche H.et al. Teniposide for brain metastases of small cell lung cancer: a phase II study. J Clin Oncol. 13:1995;660-665.
16. Twelves C., Souhami R., Harper P.et al. Chemotherapy for cerebral metastases in small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Lung Cancer. 4:1988;133-141.
17. Cotto C., Berille J., Souquet P.J.et al. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non small cell lung cancer. Eur J Cancer. 32:1996;69-71.
18. Reboul F., Vincent P., Brewer Y.et al. Chemotherapy for brain metastases of lung origin. Results of a phase II study [Abstr 1106]. Proc Am Soc Clin Oncol. 15:1996;373.
19. Furuse K., Kamimori T., Kawahara M. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small cell lung cancer with brain metastasis. Br J Cancer. 75:1997;614-618.
20. Splinter T., Sahmoud T., Festen J.et al. Two schedules of teniposide with or without cispatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 14:1996;127-134.
21. Yuichi A., Seiji S., Masahiko A.et al. Acceptability of patients with brain metastases for clinical trial of chemotherapy for metastatic non-small cell lung cancer. Am J Clin Oncol. 19:1996;478-482.
22. George S.L. Reducing patient eligibility criteria in cancer clinical trials. J Clin Oncol. 14:1996;1364-1370.
23. Tonato M., Crino' L., Mosconi A.M. Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer. Semin Oncol. 24:1997;31-35.